← BeOne Medicines Ltd.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.1m | $238.4m | $198.2m | $428.2m | $308.9m | $1.2b | $1.4b | $2.5b | $3.8b | $5.3b | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | — | — | $1.2b | — | — | — | — | |
| Cost of Revenue | $0 | $5.0m | $28.7m | $71.2m | $70.7m | $164.9m | $286.5m | $379.9m | $594.1m | $668.5m | |
| Cost of sales - product | $0 | ($5.0m) | ($28.7m) | ($71.2m) | $70.7m | $164.9m | $286.5m | $379.9m | $594.1m | $668.5m | |
| Gross Profit (derived) | $1.1m | $233.4m | $169.5m | $357.0m | $238.2m | $1.0b | $1.1b | $2.1b | $3.2b | $4.7b | |
| Research and development | ($98.0m) | ($269.0m) | ($679.0m) | ($927.3m) | $1.3b | $1.5b | $1.6b | $1.8b | $2.0b | $2.1b | |
| Selling, general and administrative | ($20.1m) | ($62.6m) | ($195.4m) | ($388.2m) | $600.2m | $990.1m | $1.3b | $1.5b | $1.8b | $2.1b | |
| Operating expenses: | |||||||||||
| Total operating expenses | ($118.1m) | ($336.8m) | ($904.0m) | ($1.4b) | $2.0b | $2.6b | $3.2b | $3.3b | $3.8b | $4.2b | |
| Operating Income (Loss) | ($117.1m) | ($98.5m) | ($705.8m) | ($959.9m) | ($1.7b) | ($1.4b) | ($1.8b) | ($1.2b) | ($568.2m) | $447.1m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | — | $250k | $894k | $1.3m | $846k | $1.7m | $4.0m | $7.2m | $4.8m | $10.1m | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | — | — | — | ($16.6m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | — | — | ($596k) | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | — | $362.9m | $0 | $0 | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | ($59.6m) | ($130.6m) | ($232.0m) | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | $11.8m | $7.6m | ($22.0m) | ($16.2m) | — | — | |
| Income (loss) from operations | ($117.1m) | ($98.5m) | ($705.8m) | ($959.9m) | ($1.7b) | ($1.4b) | ($1.8b) | ($1.2b) | ($568.2m) | $447.1m | |
| Interest income | — | — | — | — | — | — | — | $78.4m | $69.6m | $70.5m | |
| Income (loss) before income taxes | ($119.2m) | — | — | — | — | — | ($2.0b) | ($825.8m) | ($533.0m) | $416.9m | |
| Weighted-average ADSs outstanding, basic (in shares) | — | — | — | 60.1m | 83.5m | 92.8m | 103.1m | 104.4m | 105.3m | 109.1m | |
| Weighted-average ADSs outstanding, diluted (in shares) | — | — | — | 60.1m | 83.5m | 92.8m | 103.1m | 104.4m | 105.3m | 113.4m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($119.2m) | — | — | — | — | — | — | — | ($533.0m) | $416.9m | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($119.2m) | — | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | ($119.2m) | ($93.1m) | ($673.8m) | ($948.6m) | ($1.6b) | ($1.4b) | ($2.0b) | ($881.7m) | ($644.8m) | $286.9m | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($119.2m) | ($93.1m) | ($673.8m) | ($948.6m) | ($1.6b) | ($1.4b) | ($2.0b) | ($881.7m) | ($644.8m) | $286.9m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | ($194k) | ($264k) | ($1.9m) | ($3.6m) | $0 | $0 | — | — | — | |
| Earnings Per Share, Basic | — | — | — | ($15.80) | ($19.13) | ($1.17) | ($1.49) | ($0.65) | ($0.47) | $0.20 | |
| Earnings Per Share, Diluted | ($0.30) | ($2.23) | ($12.15) | ($15.80) | ($19.13) | ($1.17) | ($1.49) | ($0.65) | ($0.47) | $0.19 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | 780.7m | 1.1b | 1.2b | 1.3b | 1.4b | 1.4b | 1.4b | |
| Weighted-average shares outstanding—basic (in shares) | — | — | — | 780.7m | 1.1b | 1.2b | 1.3b | 1.4b | 1.4b | 1.4b | |
| Weighted-average shares outstanding— diluted (in shares) | — | — | — | 780.7m | 1.1b | 1.2b | 1.3b | 1.4b | 1.4b | 1.5b | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | 780.7m | 1.1b | 1.2b | 1.3b | 1.4b | 1.4b | 1.5b | |
| Research and Development Expense | $98.0m | $269.0m | $679.0m | $927.3m | $1.3b | $1.5b | $1.6b | $1.8b | $2.0b | $2.1b | |
| General and Administrative Expense | $20.1m | — | — | — | — | — | — | — | — | — | |
| Selling, General and Administrative Expense | — | $62.6m | $195.4m | $388.2m | $600.2m | $990.1m | $1.3b | $1.5b | $1.8b | $2.1b | |
| Other Nonoperating Income (Expense) | $443k | $11.5m | $2.0m | $7.2m | $37.5m | $15.9m | ($223.9m) | $307.9m | ($12.6m) | ($42.6m) | |
| Costs and Expenses | $118.1m | $336.8m | $904.0m | $1.4b | $2.0b | $2.6b | $3.2b | $3.3b | $3.8b | $4.2b | |
| Other (expense) income, net | $443k | $11.5m | $2.0m | $7.2m | $37.5m | $15.9m | ($223.9m) | $307.9m | ($12.6m) | ($42.6m) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | — | $58.2m | |
| Interest Expense, Debt | — | — | — | — | $18.3m | $29.3m | $21.7m | $20.8m | $46.9m | $50.0m | |
| Interest expense | — | — | — | — | — | — | — | ($4.4m) | ($21.8m) | ($58.2m) | |
| Current Income Tax Expense (Benefit) | $822k | $8.2m | $6.5m | $16.4m | $10.5m | $16.0m | $39.3m | $55.2m | $85.8m | $120.5m | |
| Income tax expense | ($54k) | $2.2m | $15.8m | ($7.0m) | ($17.7m) | ($25.2m) | $42.8m | $55.9m | $111.8m | $129.9m | |
| Interest Income (Expense), Net | $383k | ($4.1m) | $13.9m | $9.1m | $2.0m | ($15.8m) | $52.5m | $74.0m | — | — | |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | — | — | — | — | $47.8m | — | |
| Income Tax Expense (Benefit) | $54k | $2.2m | ($15.8m) | $7.0m | ($17.7m) | ($25.2m) | $42.8m | $55.9m | $111.8m | $129.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.